Cleared Traditional

K190386 - KTA Adipose Treatment Kit

K190386 is an FDA 510(k) clearance for KTA Adipose Treatment Kit, manufactured by Stemics S.A.S. The device is a Class 2 General & Plastic Surgery device with product code MUU cleared through the Traditional 510(k) pathway after a 233-day FDA review.

K190386 · Stemics S.A.S · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
233d
Days
Class 2
Risk

K190386 is an FDA 510(k) clearance for the KTA Adipose Treatment Kit. Classified as System, Suction, Lipoplasty (product code MUU), Class II - Special Controls.

Submitted by Stemics S.A.S (Besancon, FR). The FDA issued a Cleared decision on October 10, 2019 after a review of 233 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5040 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Stemics S.A.S devices

FDA 510(k) Submission Details - K190386

510(k) Number K190386 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2019
Decision Date October 10, 2019
Days to Decision 233 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d slower than avg
Panel avg: 115d · This submission: 233d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUU Device Classification - Class 2, Special Controls

Product Code MUU System, Suction, Lipoplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5040
Definition See Federal Register Notice At 86 Fr 50887 “consolidation Of Devices That Process Autologous Human Cells, Tissues, And Cellular And Tissue-based Products At The Point Of Care To Produce A Therapeutic Article” (frn) (fda-2021-n-0881).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Gloster Biomedical International, LLC
Catherine Gloster

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MUU System, Suction, Lipoplasty

All 10
Devices cleared under the same product code (MUU) and FDA review panel - the closest regulatory comparables to K190386.
Dermapose Refresh
K193363 · Puregraft, LLC · Apr 2020
JTL-250-01
K182732 · Jointechlabs, Inc. · Nov 2019
Progenikine Concentrating System 25 mL System
K191564 · Emcyte Corporation · Nov 2019
AuraGen 123 Suction Lipoplasty System (A123)
K190278 · Auragen Aesthetics, LLC · May 2019
Automatic Tissue Processing Unit
K172717 · Bsl Co. · May 2018
FAT CONCENTRATION SYSTEM
K100114 · Biomet, Inc. · Sep 2010